Enzo Biochem Inc. (ENZ): Growth-Adjusted Market Cap to Net Income
The foundation of Enzo Biochem, Inc. (ENZ) is its recognition in molecular diagnostics and the reliability of its DNA tests. The PEG ratio trend visualizes this potential, where 0.00 shows the current value of the metric. Stability is ensured by a staff of experienced biochemists, while future confidence is bolstered by liquidity following the sale of laboratories, allowing the company to develop intellectual property without financial risks.
Metric breakdowns and analytics for Enzo Biochem, Inc. (ENZ)
The PEG ratio determines the fairness of an asset's market value by comparing the current P/E multiple with the net income growth rate to identify undervalued expansion rates. By analyzing the level of undervaluation via PEG, an investor will see that for Enzo Biochem, Inc. (ENZ), the stagnation of operating leverage and the dependence of margins on laboratory costs limit the potential for fundamental business acceleration.
